GlassScriptPhysician profile
Randall Lee Oliver
NPI 1356393219
$3,758.11
in general payments reported to CMS, 2019-2025
40 companies · $599 in 2025
The $599 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,312 · 2020: $287 · 2021: $445 · 2022: $366 · 2023: $214 · 2024: $535 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.87 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $443.04 | 2019-2022 | |
| Nevro Corp. | $390.01 | 2019-2021 | |
| Medtronic, INC. | $280.23 | 2021-2025 | Intellis Adaptivestim |
| Supernus Pharmaceuticals, INC. | $242.64 | 2022-2024 | Qelbree, Qelbree |
| Avadel Cns Pharmaceuticals, LLC | $232.31 | 2024-2025 | Lumryz |
| Upsher-Smith Laboratories LLC | $219.71 | 2020-2023 | |
| Horizon Therapeutics Plc | $195.89 | 2022 | |
| Amgen INC. | $172.60 | 2019-2020 | |
| Curonix LLC | $141.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $123.33 | 2019 | |
| Boston Scientific Corporation | $121.13 | 2019-2024 | |
| Mml US, INC. | $90.61 | 2025 | Reactiv8 |
| Avanir Pharmaceuticals, INC. | $86.67 | 2021-2022 | |
| Alkermes, INC. | $84.89 | 2019-2023 | Vivitrol |
| Globus Medical, INC. | $81.41 | 2025 | Omnia, Vyrsa V1, Senza |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.